z-logo
open-access-imgOpen Access
Altered natural killer cell repertoire in Tap-1 mutant mice.
Author(s) -
Hans Gustaf Ljunggren,
Luc Van Kaer,
Hidde L. Ploegh,
Susumu Tonegawa
Publication year - 1994
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.91.14.6520
Subject(s) - biology , natural killer cell , mhc class i , major histocompatibility complex , microbiology and biotechnology , lymphokine activated killer cell , antigen presentation , cell , interleukin 21 , immunology , cytotoxic t cell , antigen , t cell , immune system , cd8 , in vitro , genetics
We have analyzed the specificity and function of natural killer (NK) cells in mice with a homozygous deletion of the major histocompatibility complex (MHC)-encoded transporter gene associated with MHC class I-restricted antigen presentation (Tap-1). These mice express very low levels of class I molecules at the cell surface, and these molecules are either devoid of peptide or occupied only by TAP-independent peptides. NK cells in Tap-1 -/- mice, through normal in number, appeared tolerant toward autologous Tap-1 -/- Con A-activated blasts, Tap-1 -/- as well as allogeneic BALB/c bone marrow cells, and RMA-S tumor cell grafts. In contrast, they killed YAC-1 cells as efficiently as did NK cells from wild-type mice. Defective Tap-1 expression was sufficient to render nontransformed target cells sensitive to NK cell-mediated lysis. It is concluded that proper expression of TAP molecules is necessary for normal development of NK cells, as well as for rendering target cells resistant to NK cell-mediated lysis. These results support the hypothesis that class I molecules of the MHC influence the sensitivity of target cells to lysis by NK cells, as well as the development of the NK cell repertoire.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here